Tricyclic Benzazepine vasopressin antagonists

摘要

Tricyclic compounds of the general Formula I: <IMAGE> Formula I as defined herein which exhibit antagonist activity at V1 and/or V2 receptors and exhibit in vivo vasopressin antagonist activity, methods for using such compounds in treating diseases characterized by excess renal reabsorption of water, and processes for preparing such compounds.